Life Sciences Today Podcast: Using AI to Reduce Biostatistical Analysis Readouts

AI is changing clinical development, but speed alone isn't enough. In a regulated industry, every output still has to be accurate, traceable, and ready to withstand regulatory scrutiny.

That's the central theme of Veristat’s Kyle McBride's recent conversation on the Life Sciences Today podcast with Healthcare IT Today.

Kyle discusses why successful AI adoption in biostatistics depends on more than large language models or automation. It requires validated systems, expert oversight, and workflows built specifically for clinical development.

Listen to the full episode if you're interested in the future of AI in clinical research.

The Discussion Covers:

• Why regulated AI demands a different approach than consumer AI
• How automation can help accelerate submission-ready statistical deliverables
• The importance of maintaining quality and confidence as timelines shrink
• How InStat™ by Veristat™ combines automation with biostatistical expertise to modernize analysis workflows